More and more patients are hearing about Semaglutide and other GLP-1 therapies due to their potential role in body composition changes. Originally developed to treat diabetes , these compounds operate by mimicking a inherent hormone that influences hunger and slows stomach emptying . This dual action can result in substantial slimming for many ind